Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide

INTRODUCTION: Nearly 80% of advanced prostate cancer patients respond to initial androgen deprivation therapy (ADT). However, ADT does not prevent the progression of prostate cancer over the long term, and the disease eventually progresses to castration-resistant prostate cancer (CRPC). Prior to the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomed Res Int
Hauptverfasser: Kumano, Yohei, Hasegawa, Yoriko, Kawahara, Takashi, Yasui, Masato, Miyoshi, Yasuhide, Matsubara, Nobuaki, Uemura, Hiroji
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360569/
https://ncbi.nlm.nih.gov/pubmed/30800682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9450838
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge